Abstract
Obesity is increasing rapidly throughout the world, and is predicted to double by 2025. Bariatric surgery has shown promising results, but a need for a safe and more effective procedure exists. In the last decade, there have been many publications confirming that Mini-Gastric Bypass (MGB) is a safer and equally or more effective alternative to the traditional Roux-en-Y gastric bypass. MGB has shown stronger metabolic control and more durable weight loss than the traditional bariatric operations.
The proposed mechanism behind this sustained weight loss and effective control of the metabolic syndrome is a longer biliopancreatic limb and the long gastric pouch with a wide gastric outlet, giving a low-pressure tube and thus reducing the chances of leak, nausea, and reflux in the immediate post-operative period. There are also fewer chances of dilatation in the long-term for the same reason.
The delivery of food without obstruction enables the food to be dropped into the distal jejunum, thus causing a transient dilatation of the gut and thereby giving a feeling of satiety. This mechanism may be called “non-obstructive restriction of the MGB.” Other mechanisms working behind the MGB are the gut hormones, incretins, and changes in the gut flora.
Although initially there was strong skepticism of the MGB, now the safety, durability, and reversibility of the MGB is well accepted. With this comes the understanding of the special mechanisms, justifying the multiple published good results of MGB.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
WHO Factsheet. Obesity and overweight. 2017. http://www.who.int/mediacentre/factsheets/fs311/en/.
Atallah R, Filion KB, Wakil SM, et al. Long-term effects of 4 popular diets on weight loss and cardiovascular risk factors: a systematic review of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2014;7:815–27.
Leblanc ES, O’Connor E, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:434–47.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta analysis. JAMA. 2004;292:1724–37.
Lee WJ, Ser KH, Lee YC, Tsou JJ, Chen SC, Chen JC. Laparoscopic Roux-en-Y vs mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg. 2005;242:20–8.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.
Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15:398–404.
Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses – first study from the Indian subcontinent. Obes Surg. 2014;24:1430–5.
Deitel M, Kular KS, Musella M, Carbajo M, Luque-de-Leon E. A new organisation – The MGB/OAGB Club. Bariatic News. 2015. http://www.bariatricnews.net/?q=node/2159.
BOMSS. 2014. http://www.bomss.org.uk/wp-content/uploads/2014/09/BOMSS-MGB-position-statement-September-2014.pdf.
Rutledge R, Kular KS, Deitel M. Laparoscopic mini-gastric (one-anastomosis) bypass surgery. In: Agrawal S, editor. Obesity, bariatric and metabolic surgery: a practical guide. Switzerland: Springer Science; 2016. p. 415–23.
Niv E, Fireman Z, Vaisman N. Post-pyloric feeding. World J Gastroenterol. 2009;15:1281–8. https://doi.org/10.3748/wjg.15.1281.
Dorman RB, Ikramuddin S. Laparoscopic Roux-en-Y gastric bypass: techniques and outcomes. In:The SAGES manual. New York: Springer. p. 13–25.
Hall JE. Guyton and hall textbook of medical physiology, Unit XII, gastrointestinal physiology. Elsevier: Philadelphia, PA; 2015. p. 834.
Odstrcil EA, Martinez JG, Santa Ana CA, Xue B, Schneider RE, Steffer KJ, Porter JL, Asplin J, Kuhn JA, Fordtran JS. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704–13.
Svanevik M, Risstad H, Hofsø D, Schou CF, Solheim B, Søvik TT, Kristinsson J, Hjelmesæth J, Mala T, Sandbu R. Perioperative outcomes of proximal and distal gastric bypass in patients with BMI ranged 50–60 kg/m2 – A double-blind, randomized controlled trial. Obes Surg. 2015;25:1788–95.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26:926–32.
Suárez Llanos JP, Fuentes Ferrer M, Alvarez-Sala-Walther L, García Bray B. Medina González L4 Bretón Lesmes I, Moreno Esteban B. Protein malnutrition incidence comparison after gastric bypass versus biliopancreatic diversion. Nutr Hosp. 2015;32:80–6.
Ukleja A. Nutrition issues in Gastroenterology, series #35, Integrative Nutrition Therapy. 2016. p 270.
Deitel M. The change in the dumping syndrome concept. Obes Surg. 2008;18:1622–4.
Emous M, Wolffenbuttel BHR, Totté E, van Beek AP. The short- to mid-term symptom prevalence of dumping syndrome after primary gastric-bypass surgery and its impact on health-related quality of life. Surg Obes Relat Dis. 2017;13:1489–500. https://doi.org/10.1016/j.soard.2017.04.028.
Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96:e1372–9.
Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond). 2009;33:S33–40.
Lee WJ, Chong K, Lin YH, Wei JH, Chen SC. Laparoscopic sleeve gastrecomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24:1552–62.
Troseid M, Nestvold TK, Rudi K, Thoresen H, Nielsen EW, Lappegard KT. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care. 2013;36:3627–32.
Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17:1671–7.
Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55:2319–26.
Rubino F. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care. 2006;9:497–507.
Kashyap S, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond). 2010;34:462–71.
Liou AP, Paziuk M, Luevano JM, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5(178):178ra41.
Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29(Suppl 1):1–49.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Kular, K.S., Manchanda, N., Rutledge, R. (2018). Physiology of the MGB: How It Works for Long-Term Weight Loss. In: Deitel, M. (eds) Essentials of Mini ‒ One Anastomosis Gastric Bypass. Springer, Cham. https://doi.org/10.1007/978-3-319-76177-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-76177-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76176-3
Online ISBN: 978-3-319-76177-0
eBook Packages: MedicineMedicine (R0)